The authors also show that pulmonary hypertension and vascular fibrosis are attenuated by inhibition of NEDD9, further confirming our findings that NKX2-5 is a critical regulator of vascular remodeling. This evidence concerns the gene NKX2-5 and pulmonary arterial hypertension.